Skip to content
Subscriber Only
Business
Prognosis

Astra-Oxford Shot Is Key to Escaping Pandemic for Many Nations

  • Vaccine makes up 40% of low-, middle-income countries’ supply
  • World awaits Astra data after strong Pfizer, Moderna results
Video player cover image
Oxford-AstraZeneca Vaccine `Much Easier to Distribute': Lancet Editor

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Trial successes from Pfizer Inc. and Moderna Inc. have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside of rich nations like the U.S., is counting on another company’s shot to escape the crisis.